Related Experiment Videos
Congenital chylothorax
K Al-Tawil1, G Ahmed, M Al-Hathal
1Department of Pediatrics, King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
American Journal of Perinatology
|September 30, 2000
Summary
Congenital chylothorax in infants has a 100% survival rate with current treatments. Early use of breast milk or standard formula is recommended before considering medium-chain triglyceride (MCT) rich formulas.
Area of Science:
- Pediatrics
- Neonatology
- Thoracic Surgery
Background:
- Congenital chylothorax is a rare condition in newborns.
- It involves the accumulation of lymphatic fluid in the chest cavity.
- Management strategies and outcomes require further investigation.
Purpose of the Study:
- To conduct a retrospective study of infants treated for congenital chylothorax.
- To analyze management, outcomes, and complications in two international hospitals.
- To evaluate the prognosis of congenital chylothorax based on various factors.
Main Methods:
- Retrospective review of infant medical records from Royal Children's Hospital (1982-1994) and King Fahad National Guard Hospital (1992-1998).
- Inclusion criteria: all infants treated for congenital chylothorax.
- Data collected: management strategies, duration of ventilation and TPN, complications, and survival rates.
Main Results:
- Nineteen infants (13 female, 8 male) were studied.
- 100% survival rate was achieved regardless of treatment modality.
- Hydropic infants experienced longer ventilation and hospital stays compared to non-hydropic infants.
Conclusions:
- Congenital chylothorax, even in the presence of hydrops fetalis, has a good prognosis in term and preterm infants.
- Initial management should prioritize breast milk or standard infant formula.
- Surgical intervention is reserved for cases refractory to conservative management for 4-5 weeks.